These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30826464)

  • 1. Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.
    Murata M; Takenaka K; Uchida N; Ozawa Y; Ohashi K; Kim SW; Ikegame K; Kanda Y; Kobayashi H; Ishikawa J; Ago H; Hirokawa M; Fukuda T; Atsuta Y; Kondo T
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1536-1543. PubMed ID: 30826464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT.
    Murata M; Nishida T; Taniguchi S; Ohashi K; Ogawa H; Fukuda T; Mori T; Kobayashi H; Nakaseko C; Yamagata N; Morishima Y; Nagamura-Inoue T; Sakamaki H; Atsuta Y; Suzuki R; Naoe T
    Bone Marrow Transplant; 2014 Mar; 49(3):355-60. PubMed ID: 24270391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
    Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myelogenous Leukemia: A Comparative Analysis.
    Yanada M; Konuma T; Yamasaki S; Harada K; Iwasaki M; Kobayashi A; Nishijima A; Tanaka M; Uchida N; Nakamae H; Fukuda T; Onizuka M; Ozawa Y; Sawa M; Katayama Y; Yoshioka S; Kimura T; Ichinohe T; Atsuta Y; Kanda J; Yano S
    Transplant Cell Ther; 2021 Dec; 27(12):1005.e1-1005.e8. PubMed ID: 34500125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.
    Waller EK; Logan BR; Harris WA; Devine SM; Porter DL; Mineishi S; McCarty JM; Gonzalez CE; Spitzer TR; Krijanovski OI; Linenberger ML; Woolfrey A; Howard A; Wu J; Confer DL; Anasetti C
    J Clin Oncol; 2014 Aug; 32(22):2365-72. PubMed ID: 24982459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.
    Barker JN; Krepski TP; DeFor TE; Davies SM; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2002; 8(5):257-60. PubMed ID: 12064362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis.
    Murata M; Suzuki R; Nishida T; Shirane S; Shimazu Y; Minami Y; Mori T; Doki N; Kanda Y; Uchida N; Tanaka M; Ishikawa J; Togitani K; Fukuda T; Ichinohe T; Atsuta Y; Nagamura-Inoue T; Kiyoi H
    Intern Med; 2020; 59(16):1947-1956. PubMed ID: 32801269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
    McLornan D; Szydlo R; Koster L; Chalandon Y; Robin M; Wolschke C; Beelen D; Socié G; Bornhäuser M; Angelucci E; Niederwieser D; Gerbitz A; Finke J; Vitek A; Itälä-Remes M; Radujkovic A; Kanz L; Potter V; Chevallier P; Stelljes M; Petersen E; Robinson S; Poiré X; Klyuchnikov E; Hernández-Boluda JC; Czerw T; Hayden P; Kröger N; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2167-2171. PubMed ID: 31284069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes.
    O'Donnell PV; Brunstein CG; Fuchs EJ; Zhang MJ; Allbee-Johnson M; Antin JH; Leifer ES; Elmariah H; Grunwald MR; Hashmi H; Horowitz MM; Magenau JM; Majhail N; Milano F; Morris LE; Rezvani AR; McGuirk JP; Jones RJ; Eapen M
    Transplant Cell Ther; 2022 Feb; 28(2):109.e1-109.e8. PubMed ID: 34775146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis.
    Keyzner A; Han S; Shapiro S; Moshier E; Schorr E; Petersen B; Najfeld V; Kremyanskaya M; Isola L; Hoffman R; Mascarenhas J
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2180-2186. PubMed ID: 27596130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type.
    Subramanian S; Cohn C; DeFor T; Welbig J; Brunstein C; El Jurdi N; Weisdorf D
    Transfusion; 2021 Jul; 61(7):2064-2074. PubMed ID: 33899243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Donor Sources in Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Nationwide Retrospective Study.
    Sakaguchi H; Watanabe N; Matsumoto K; Yabe H; Kato S; Ogawa A; Inagaki J; Goto H; Koh K; Yoshida N; Kato K; Cho Y; Kosaka Y; Takahashi Y; Inoue M; Kato K; Atsuta Y; Miyamura K;
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2226-2234. PubMed ID: 27667011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell transplantation in pediatric patients with acute leukemias or myelodysplastic syndrome using unrelated adult or umbilical cord blood donors in Brazil.
    Tavares RCB; Bonfim CS; Seber A; Pereira Lermontov S; Coulturato V; Zecchin VG; Ribeiro L; Fernandes JF; Daudt LE; Grecco CS; Darrigo-Jr LG; Villela N; Nichele S; Gouveia R; Bouzas LF; Hamerschlak N; Vigorito AC; da Silva PM; da Silva PO; da Silva CC; de Souza Fernandez C; Flowers ME; Arcuri LJ
    Pediatr Transplant; 2020 Nov; 24(7):e13789. PubMed ID: 32757316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
    Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.
    Mehta RS; Holtan SG; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Alousi AM; Pidala J; Abdel-Azim H; Agrawal V; Ahmed I; Al-Homsi AS; Aljurf M; Antin JH; Askar M; Auletta JJ; Bhatt VR; Chee L; Chhabra S; Daly A; DeFilipp Z; Gajewski J; Gale RP; Gergis U; Hematti P; Hildebrandt GC; Hogan WJ; Inamoto Y; Martino R; Majhail NS; Marks DI; Nishihori T; Olsson RF; Pawarode A; Diaz MA; Prestidge T; Rangarajan HG; Ringden O; Saad A; Savani BN; Schoemans H; Seo S; Schultz KR; Solh M; Spitzer T; Storek J; Teshima T; Verdonck LF; Wirk B; Yared JA; Cahn JY; Weisdorf DJ
    J Clin Oncol; 2020 Jun; 38(18):2062-2076. PubMed ID: 32364845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BM is preferred over PBSCs in transplantation from an HLA-matched related female donor to a male recipient.
    Nakasone H; Kawamura K; Yakushijin K; Shinohara A; Tanaka M; Ohashi K; Ota S; Uchida N; Fukuda T; Nakamae H; Matsuoka KI; Kanda J; Ichinohe T; Atsuta Y; Inamoto Y; Seo S; Kimura F; Ogata M
    Blood Adv; 2019 Jun; 3(11):1750-1760. PubMed ID: 31182560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploidentical
    Brissot E; Labopin M; Ehninger G; Stelljes M; Brecht A; Ganser A; Tischer J; Kröger N; Afanasyev B; Finke J; Elmaagacli A; Einsele H; Mohty M; Nagler A
    Haematologica; 2019 Mar; 104(3):524-532. PubMed ID: 30361416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HLA in cord blood transplantation outcomes.
    Ruggeri A; Paviglianiti A; Gluckman E; Rocha V
    HLA; 2016 Jun; 87(6):413-21. PubMed ID: 27060588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.